NCT02179918 A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036) Status COMPLETED Phase PHASE1
NCT02134067 Dose-escalating, Safety, Tolerability and PK Study of TAS-119 in Combination With Paclitaxel in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02122770 Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02110355 A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma Status COMPLETED Phase PHASE1
NCT02057380 A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial Status COMPLETED Phase PHASE2
NCT02040558 Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02031055 Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01999972 A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01989546 Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations Status COMPLETED Phase PHASE1/PHASE2
NCT01980667 Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01953783 Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB Status COMPLETED Phase PHASE1
NCT01946789 A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01940133 A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 Status COMPLETED Phase PHASE1
NCT01938612 A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT01912222 Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction Status COMPLETED Phase PHASE1
NCT01910597 Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1